Delaying surgery beyond six weeks after systemic therapy reduces postoperative morbidity without evidence of impaired oncologic outcomes in colorectal liver metastases - Report - MDSpire

Delaying surgery beyond six weeks after systemic therapy reduces postoperative morbidity without evidence of impaired oncologic outcomes in colorectal liver metastases

  • By

  • Esther Giehl-Brown

  • Rajan Nikbakhsh

  • Ana Mansourkiaei

  • Laila Jötten

  • Bruno Christian Köhler

  • Thomas Longerich

  • Bo Kong

  • Arianeb Mehrabi

  • Markus W Büchler

  • Mohammed Al-Saeedi

  • Christoph Kahlert

  • June 30, 2026

  • 0 min

Share

Postponing Surgery Beyond Six Weeks After Systemic Treatment Lowers Postoperative Complications

Overview

This study evaluates the impact of time-to-surgery (TTS) on postoperative complications and oncological outcomes in patients with colorectal liver metastases (CRLM) following neoadjuvant systemic therapy (NAT).

Background

Colorectal liver metastases (CRLM) are a significant challenge in colorectal cancer management, with surgical resection being the only potentially curative option. The timing of surgery after neoadjuvant systemic therapy (NAT) is critical, as it may influence both postoperative morbidity and long-term survival.

Data Highlights

No numerical data was provided in the source material.

Key Findings

  • 159 patients were included in the retrospective analysis from a high-volume tertiary center.
  • Postoperative morbidity was assessed using a Comprehensive Complication Index (CCI) > 30 within 90 days of surgery.
  • Delaying surgery beyond six weeks after NAT was associated with lower postoperative complications.
  • Oncological outcomes, including recurrence-free survival (RFS) and overall survival (OS), were not compromised by the delay.
  • Optimal timing of surgery remains a critical factor in managing CRLM post-NAT.

Clinical Implications

Clinicians should consider postponing surgery for patients with CRLM beyond six weeks after completing NAT to potentially reduce postoperative complications. This approach may enhance patient safety without adversely affecting oncological outcomes.

Conclusion

The findings indicate that a delay in surgical intervention after NAT can lead to improved postoperative outcomes in patients with CRLM.

Related Resources & Content

  1. The ASCO Post, 2026 -- Colorectal Cancer Liver Metastases: Transplant or Resect?
  2. EORTC consensus recommendations on the optimal management of colorectal cancer liver metastases - ScienceDirect
  3. First-Line Systemic Treatment for Initially Unresectable Colorectal Liver Metastases: Post Hoc Analysis of the CAIRO5 Randomized Clinical Trial | Trials | JAMA Oncology | JAMA Network
  4. Chemotherapy-associated liver injury in colorectal cancer - PMC
  5. The ASCO Post — Colorectal Cancer Liver Metastases: Transplant or Resect?
  6. The ASCO Post — Colorectal Cancer Liver Metastases: Transplant or Resect?
  7. The Impact of Postponing Curative Surgery on Long-Term Disease-Free Survival in Colorectal Cancer: A Cohort Analysis
  8. EORTC consensus recommendations on the optimal management of colorectal cancer liver metastases - ScienceDirect
  9. First-Line Systemic Treatment for Initially Unresectable Colorectal Liver Metastases: Post Hoc Analysis of the CAIRO5 Randomized Clinical Trial | Trials | JAMA Oncology | JAMA Network
  10. Chemotherapy-associated liver injury in colorectal cancer - PMC

Original Source(s)

Related Content